Biochimica et Biophysica Acta (BBA)-Biomembranes 1862(9):183330 Kakogiannos N, Ferrari L, Giampietro C, Scalise AA, Maderna C, Rav M et al (2020) JAM-A acts via C/EBP- to promote claudin-5 expression and enhance endothelial barrier function
Semaglutide, tirzepatide, and liraglutide are FDA-approved GLP-1 peptides that are clinically safe and effective for diabetes and weight management
The FDA-approved semaglutide comes in injectable pens, but most of the compounded drug is distributed in a vial with a syringe, making it easier to measure in smaller increments
Monitoring for persistent inflammation at the injection site is a vital feedback loop
Untreated chronic obesity can progress into diabetes, heart disease, sleep apnea, kidney disease, disability and other expensive conditions